Biotechnology Analysis & Statistics, November 2013 (p40)

Talk to Louis

+1 718 618 4302

Publishers

All regions

You might be interested in: biotech, biomedical, protein, more »

1171-1200 of about 2 800 reports

Purchase Reports From Reputable Market Research Publishers

Taiyen Biotech Co., Ltd (Symbol:1737) SWOT Analysis, Strategy, Revenues and Profits

Taiyen Biotech Co., Ltd (Symbol:1737) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
Oneness Biotech Co., Ltd. (Symbol:4743) SWOT Analysis, Strategy, Revenues and Profits

Oneness Biotech Co., Ltd. (Symbol:4743) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
Abl Biotechnologies Limited (Symbol:526955) SWOT Analysis, Strategy, Revenues and Profits

Abl Biotechnologies Limited (Symbol:526955) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
XTL Biopharmaceuticals Ltd. (Symbol:XTLBY) SWOT Analysis, Strategy, Revenues and Profits

XTL Biopharmaceuticals Ltd. (Symbol:XTLBY) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
Citurgia Biochemicals Ltd. (506373) - Financial and Strategic SWOT Analysis Review

Citurgia Biochemicals Ltd. (506373) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Citurgia Biochemicals Ltd. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Biotechnology
Nventa Biopharmaceuticals Corp. (NVN) - Strategic SWOT Analysis Review

Nventa Biopharmaceuticals Corp. (NVN) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Nventa Biopharmaceuticals Corp. provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clea ...

  • Industries : Biopharmaceutical
Tianjin TEDA Biomedical Co., Ltd. (8189) - Financial and Strategic SWOT Analysis Review

Tianjin TEDA Biomedical Co., Ltd. (8189) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Tianjin TEDA Biomedical Co., Ltd. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Biopharmaceutical
Malaysian Genomics Resource Centre Berhad (GENOME) - Financial and Strategic SWOT Analysis Review

Malaysian Genomics Resource Centre Berhad (GENOME) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Malaysian Genomics Resource Centre Berhad provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled ...

  • Industries : Genomics
  • Countries : Malaysia
China Dasheng Biotechnology Co (CDBT) - Strategic SWOT Analysis Review

China Dasheng Biotechnology Co (CDBT) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of China Dasheng Biotechnology Co provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clea ...

  • Industries : Biotechnology
  • Countries : China
Saamya Biotech (Symbol:India) SWOT Analysis, Strategy, Revenues and Profits

Saamya Biotech (Symbol:India) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : India
Guangdong By-Health Biotechnology Co., Ltd. (300146) - Financial and Strategic SWOT Analysis Review

Guangdong By-Health Biotechnology Co., Ltd. (300146) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Guangdong By-Health Biotechnology Co., Ltd. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled ...

  • Industries : Biotechnology
Chongqing Zhifei Biological Products Co., Ltd. (300122) - Financial and Strategic SWOT Analysis Review

Chongqing Zhifei Biological Products Co., Ltd. (300122) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Chongqing Zhifei Biological Products Co., Ltd. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled ...

  • Industries : Biotechnology
Bloomage BioTechnology Corporation Ltd (Symbol:963) SWOT Analysis, Strategy, Revenues and Profits

Bloomage BioTechnology Corporation Ltd (Symbol:963) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
Sterling Biotech Limited (STERLINBIO) - Financial and Strategic SWOT Analysis Review

Sterling Biotech Limited (STERLINBIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Sterling Biotech Limited provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Biotechnology
Biomarkers: Discovery Techniques and Applications - A Global Market Overview

Biomarkers: Discovery Techniques and Applications - A Global Market Overview

  • $ 4 500
  • Industry report
  • November 2013
  • by Industry Experts

The potential offered by biomarkers in shaping the outcomes of clinical trials, identifying new drug targets and developing diagnostic assays for detecting diseases early is immense, which has ensued in ...

  • Industries : Genomics
  • Countries : United States, World, Europe
Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective

Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective

  • $ 2 495
  • Industry report
  • November 2013
  • by CHI Insight Pharma Reports

This report covers several technologies, epigenetic targets, and market outlook. The first part of this report covers necessary background information, mostly pertaining to epigenetic targets, and the ...

  • Industries : Biopharmaceutical
DNA Sequencing and PCR Markets

DNA Sequencing and PCR Markets

  • $ 3 400
  • Industry report
  • November 2013
  • by TriMark Publications

DNA sequencing and polymerase chain reaction (PCR) are two major technology platforms of value in life science research, drug discovery and clinical diagnostics. The markets for sequencing are extremely ...

  • Industries : Genomics
  • Countries : World
European Markets for Orthopedic Biomaterials - Executive Summary

European Markets for Orthopedic Biomaterials - Executive Summary

  • $ 295
  • Industry report
  • November 2013
  • by iData Research, Inc.

Summary for: The European orthopedic biomaterials market is expected to reach €376.7 million by 2019, with hyaluronic acid viscosupplementation as the largest segment. The European orthopedic biomaterials ...

  • Industries : Biomaterial
  • Countries : Europe
European Markets for Orthopedic Biomaterials

European Markets for Orthopedic Biomaterials

  • $ 8 995
  • Industry report
  • November 2013
  • by iData Research, Inc.

The European orthopedic biomaterials market is expected to reach €376.7 million by 2019, with hyaluronic acid viscosupplementation as the largest segment. The European orthopedic biomaterials market ...

  • Industries : Biomaterial
  • Countries : Europe
Commercialisation of Biosimilars: strategies for market penetration

Commercialisation of Biosimilars: strategies for market penetration

  • $ 495
  • Industry report
  • November 2013
  • by Firstword Pharma

Introduction Times, they are a-changin'—at least for the American biological product market. With five major biological products worth a collective US$35 billion in annual sales now facing imminent patent ...

  • Industries : Biopharmaceutical
  • Countries : United States
Physician Views: Oncologist reaction to Roche's Gazyva - US approval and new late-stage data versus Rituxan

Physician Views: Oncologist reaction to Roche's Gazyva - US approval and new late-stage data versus Rituxan

  • $ 645
  • Industry report
  • November 2013
  • by Firstword Pharma

Scope Roche's efforts to enhance its dominance of the haematological cancer market received notable momentum last week when the company gained FDA approval for Gazyva as a first-line treatment for chronic ...

  • Industries : Biological Therapy
  • Countries : United States
Global And China Industrial Enzyme Industry 2013 Market Research Report

Global And China Industrial Enzyme Industry 2013 Market Research Report

  • $ 2 200
  • Industry report
  • November 2013
  • by QY Research Group

Description The report firstly introduced Industrial Enzyme basic information included Industrial Enzyme definition classification application industry chain structure industry overview; international ...

  • Industries : Biopharmaceutical
  • Countries : China
Global Synthetic Biology Industry

Global Synthetic Biology Industry

  • $ 4 500
  • Industry report
  • November 2013
  • by Global Industry Analysts

This report analyzes the worldwide markets for Synthetic Biology in US$ Thousands by the following Application Areas: Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others. The report provides ...

  • Industries : Genetically Modified Organism, Gmo
  • Countries : World
Pharmaceutical Market: India A Comprehensive Industry Analysis Q3 2013

Pharmaceutical Market: India A Comprehensive Industry Analysis Q3 2013

  • $ 2 000
  • Industry report
  • November 2013
  • by Kelly Scientific Publications

“Pharmaceutical Market: India, A Competitive Industry Analysis Q3 2013” by Kelly Scientific Publications is a comprehensive report on the pharmaceutical and biotechnology industry in India and its ...

  • Industries : Biopharmaceutical
  • Countries : India
Quotient Biodiagnostics - Product Pipeline Analysis, 2013 Update

Quotient Biodiagnostics - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Industry report
  • October 2013
  • by Global Data

Summary Quotient Biodiagnostics (Quotient) is a medical device company. The company develops, manufactures and markets immunohematology products to hospitals and blood banks. It offers products such as ...

  • Industries : Biopharmaceutical
  • Countries : United States
Shin Nippon Biomedical Laboratories, Ltd. - Product Pipeline Review - 2013

Shin Nippon Biomedical Laboratories, Ltd. - Product Pipeline Review - 2013

  • $ 1 500
  • Company report
  • October 2013
  • by Global Markets Direct

Shin Nippon Biomedical Laboratories, Ltd. - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, “Shin Nippon Biomedical Laboratories, Ltd. - Product Pipeline Review ...

  • Industries : Biopharmaceutical
  • Countries : World
Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth

Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth

  • $ 3 500
  • Industry report
  • October 2013
  • by GBI Research

Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth Summary GBI Research has released the pharmaceutical report “Monoclonal ...

  • Industries : Biopharmaceutical
  • Countries : World
Bone Regeneration - Pipeline Review, H2 2013

Bone Regeneration - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Bone Regeneration - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Bone Regeneration - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report ...

  • Industries : Biological Therapy
  • Countries : World
Competitor Analysis: CD19-Targeted Therapeutics

Competitor Analysis: CD19-Targeted Therapeutics

  • $ 264
  • Industry report
  • October 2013
  • by La Merie Publishing

Renewed interest in CD19 as target for antibody and T-cell Therapeutics The human CD19 antigen is a 95 kd transmembrane glycoprotein. It is specifically expressed in normal and neoplastic B cells, ...

  • Industries : Biological Therapy
GMO HOSTING & SECURITY, INC. (Symbol:3788) SWOT Analysis, Strategy, Revenues and Profits

GMO HOSTING & SECURITY, INC. (Symbol:3788) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genetically Modified Organism, Gmo
About 6 400 reports

Download Unlimited Documents from Trusted Public Sources

Vaccine Industry in the US

  • Human Papillomavirus Vaccination
  • August 2014
    36 pages
  • Vaccine  

    Cancer  

  • United States  

    North America  

View report >

Protein Supply

August 2014

About 100 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Biogen Idec

United States

Abbott Laboratories

United States

Life Technologies Corp.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.